{
    "medicine_id": "802e7fed6b089447bd1b690efb3a39d4862c4c01",
    "platform_id": "DB04886",
    "metadata": {
        "name": "Galvus 50 mg Tablet",
        "composition": "50 mg Calanolide A",
        "clinical_particulars": {
            "therapeutic_indications": "For use in combination treatment of HIV infection AIDS",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Calanolide A is a new non nucleoside reverse transcriptase inhibitor NNRTI derived from a plant found in the Malaysian rain forest A related compound calanolide B also has anti HIV activity Both drugs are being developed by Sarawak Pharmaceuticals The drug is metabolised by cytochrome P450 CYP3A and its developers have suggested that drug levels may be enhanced if co administered with ritonavir Norvir The drug is active in the test tube against HIV with the two most common NNRTI related mutations K103N and Y181C and selects for a mutation which does not cause cross resistance with any other NNRTIs currently under investigation A substitution at codon Y188H of reverse transcriptase has been associated with 30 fold resistance to calanolide A in vitro Quan 1999 The compound is essentially inactive against strains of the less common HIV type 2",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB10317",
                        "description": "The therapeutic efficacy of Rubella virus vaccine can be decreased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB10343",
                        "description": "The therapeutic efficacy of Bacillus calmette guerin substrain tice live antigen can be decreased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB10804",
                        "description": "The therapeutic efficacy of Bacillus calmette guerin substrain connaught live antigen can be decreased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB10805",
                        "description": "The therapeutic efficacy of Yellow Fever Vaccine can be decreased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB11003",
                        "description": "The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB11050",
                        "description": "The therapeutic efficacy of Typhoid Vaccine Live can be decreased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB12386",
                        "description": "The therapeutic efficacy of Bacillus calmette guerin substrain danish 1331 live antigen can be decreased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB12768",
                        "description": "The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB14409",
                        "description": "The therapeutic efficacy of Human adenovirus e serotype 4 strain cl 68578 antigen can be decreased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB14443",
                        "description": "The therapeutic efficacy of Vibrio cholerae CVD 103 HgR strain live antigen can be decreased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB14685",
                        "description": "The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB10318",
                        "description": "The therapeutic efficacy of Varicella Zoster Vaccine Live attenuated can be decreased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "The serum concentration of the active metabolites of Calanolide A can be increased when Calanolide A is used in combination with Dexmethylphenidate"
                    },
                    {
                        "drugbank-id": "DB00222",
                        "description": "The therapeutic efficacy of Glimepiride can be increased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB00414",
                        "description": "The therapeutic efficacy of Acetohexamide can be increased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB00672",
                        "description": "The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB00839",
                        "description": "The therapeutic efficacy of Tolazamide can be increased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB01016",
                        "description": "The therapeutic efficacy of Glyburide can be increased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "The therapeutic efficacy of Glipizide can be increased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB01120",
                        "description": "The therapeutic efficacy of Gliclazide can be increased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "The therapeutic efficacy of Tolbutamide can be increased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB01251",
                        "description": "The therapeutic efficacy of Gliquidone can be increased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB01289",
                        "description": "The therapeutic efficacy of Glisoxepide can be increased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB08962",
                        "description": "The therapeutic efficacy of Glibornuride can be increased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB13406",
                        "description": "The therapeutic efficacy of Carbutamide can be increased when used in combination with Calanolide A"
                    },
                    {
                        "drugbank-id": "DB13675",
                        "description": "The therapeutic efficacy of Metahexamide can be increased when used in combination with Calanolide A"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}